Peptide profile · Weight Management
Semaglutide
The revolutionary once-weekly GLP-1 medication that helps your body feel full faster and longer, leading to significant weight loss while also protecting your heart—FDA approved and backed by some of the largest clinical trials in obesity medicine history.
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Dose timeline
0.25 mg
Start · 4 weeks
0.5-1 mg
Maintenance · At least 4 weeks at each step
2-2.4 mg
Maximum · Ongoing/maintenance
Half-life
Approximately 7 days (168 hours)
Bioavailability
89% (subcutaneous); 0.4-1% (oral, with absorption enhancer)
Molecular weight
4113.58 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C187H291N45O59
Primary benefits
Produces 15%+ average body weight loss in clinical trials—among the most effective non-surgical weight loss interventions ever studied
Dramatically reduces hunger and food cravings by mimicking natural satiety hormones, making portion control feel effortless rather than forced
Proven 20% reduction in cardiovascular events (heart attacks, strokes, CV death) in the SELECT trial—a first for weight loss medications
Novo Nordisk
Amino acid sequence
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 fatty diacid-γGlu-OEG-OEG)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly02 · Dosing
How much do I take?
0.25 mg, titrated to 0.5-1 mg · once weekly
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Choose any day of the week that works for your schedule and stick with it. Many people prefer Sunday or Monday to make it easy to remember. Take it at roughly the same time each week, though the exact hour doesn't matter much due to the long half-life.
With food?
Semaglutide injections can be taken with or without food—it doesn't affect absorption. However, because the medication slows stomach emptying, eating smaller meals will help reduce nausea. The oral version (Rybelsus) MUST be taken on an empty stomach with a small amount of water.
If stacking
Semaglutide is typically used as a standalone weight management therapy. If using with other diabetes medications, especially insulin or sulfonylureas, doses of those medications may need to be reduced to prevent low blood sugar. Always coordinate with your healthcare provider.
＋ Increase if
- +You've tolerated the current dose for 4+ weeks without significant GI issues
- +Weight loss has plateaued and you haven't reached target dose
- +Blood sugar targets aren't being met (for diabetes patients)
- +Your healthcare provider recommends progression based on your response
－ Decrease if
- −Nausea, vomiting, or diarrhea are severe and persistent
- −You're unable to eat enough to maintain basic nutrition
- −You experience signs of dehydration from GI symptoms
- −Side effects significantly impact your quality of life
✓ Signs of right dose
- ✓Steady weight loss of 1-2 pounds per week
- ✓Feeling satisfied with smaller portions
- ✓Reduced food cravings and thoughts about food
- ✓Manageable or no GI side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for significant weight loss & long-term weight management
Best for
People with Obesity Seeking Significant Weight Loss
If your BMI is 30 or higher (or 27+ with weight-related health conditions), semaglutide is currently one of the most effective non-surgical weight loss options available. Clinical trials show average weight loss of 15% of body weight—that's 30+ pounds for someone starting at 200 pounds.
Those Who've Struggled with Diet and Exercise Alone
Semaglutide works by changing the biological signals that drive hunger and cravings. If you've tried to lose weight through willpower alone and found yourself constantly battling hunger, this medication addresses that underlying biology rather than just telling you to eat less.
People with Type 2 Diabetes Needing Better Control
Originally developed for diabetes, semaglutide excellently controls blood sugar while also promoting weight loss—addressing two major health concerns simultaneously. It can often allow people to reduce or eliminate other diabetes medications.
Individuals at High Cardiovascular Risk
The SELECT trial proved that semaglutide reduces heart attacks, strokes, and cardiovascular death by 20% in people with obesity and existing heart disease—even without diabetes. It's one of the few weight loss medications proven to improve hard cardiovascular outcomes.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Semaglutide with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Subcutaneous injection · Oral tablet
Reconstitution — what you need
Example
Semaglutide comes in pre-filled, pre-measured pens. For Wegovy: Starter pens contain set doses (0.25mg, 0.5mg, etc.) that you select. For Ozempic: The pen dial lets you select your dose (0.25mg, 0.5mg, 1mg, or 2mg). No calculations needed—the pen does the measuring for you.
Simply dial your prescribed dose on the pen. For example, if prescribed 0.5mg weekly, turn the dose selector to 0.5mg and inject. The pen window shows your selected dose. One pen typically contains multiple doses depending on your prescription.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—quick, relatively painless, and can be self-administered at home
Best sites
Technique
- 01Remove pen cap and attach a new needle—never reuse needles
- 02Clean injection site with alcohol swab and let it air dry
- 03If using a new pen, prime it according to package instructions
- 04Dial your prescribed dose on the pen
- 05Pinch skin at injection site and insert needle straight in (90-degree angle)
- 06Press and hold the dose button until the dose counter shows 0
- 07Keep the button pressed and count slowly to 6 before removing needle
- 08Remove needle, dispose in sharps container, and replace pen cap
Storage · before reconstitution
Store new, unopened pens in the refrigerator at 36-46°F (2-8°C). Do not freeze—freezing destroys the medication. Keep in original carton to protect from light. If needed, unopened pens can be stored at room temperature (up to 86°F/30°C) for up to 28 days before first use.
Storage · after reconstitution
After first use, pens can be stored in the refrigerator or at room temperature up to 86°F (30°C). Use within 56 days of first injection. Always replace the pen cap after use to protect from light. Never store with needle attached.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
4 common side effects · 3 serious
Semaglutide has been studied in over 20,000 participants across multiple large clinical trials, making it one of the most thoroughly researched weight loss medications available. The FDA approved it after rigorous review of safety data. While GI side effects are common (especially early on), serious side effects are rare. The SELECT trial showed it actually reduces cardiovascular events, adding a safety benefit beyond just weight loss.
The safety profile is supported by multiple Phase 3 trials including STEP 1-4 (weight loss) and SELECT (cardiovascular outcomes), with follow-up extending to nearly 4 years. Long-term studies continue, and post-marketing surveillance actively monitors for rare adverse events. The thyroid tumor signal seen in rodents has not been confirmed in humans after years of widespread use.
Common side effects · experienced by some users
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- ×Severe or persistent nausea and vomiting that prevents adequate nutrition despite dose adjustments
- ×Signs of pancreatitis—severe abdominal pain radiating to the back
- ×Allergic reaction—rash, itching, swelling, difficulty breathing
- ×Signs of thyroid tumors—neck lump, hoarseness, trouble swallowing
- ×Pregnancy or planning to become pregnant (stop at least 2 months before conception)
- ×Severe kidney problems or dehydration from GI symptoms
- ×Your healthcare provider recommends discontinuation
Semaglutide is a prescription medication that should only be started, adjusted, or stopped under medical supervision. This information is educational and does not replace professional medical advice. Stopping suddenly is generally safe, but discuss any changes with your healthcare provider.
With other peptides
- !Other GLP-1 Agonists (liraglutide, tirzepatide) — Never combine GLP-1 medications—they work through the same mechanism and combining would increase side effects without additional benefit.
- ✓BPC-157 — No direct interaction data exists. BPC-157 is sometimes used for GI healing, which could theoretically help with semaglutide's GI side effects, but this is speculative.
- ✓Growth Hormone Peptides — Limited interaction data. Some users combine them, but this should be done under medical supervision as both can affect glucose metabolism.
With medications
- !Insulin — Semaglutide enhances insulin's blood sugar-lowering effect. Insulin doses typically need to be reduced 20-50% when starting semaglutide to prevent hypoglycemia. Work closely with your doctor.
- !Sulfonylureas (glipizide, glyburide) — High risk of hypoglycemia when combined. Sulfonylurea dose usually needs reduction. Monitor blood sugar closely.
- ✓Oral Contraceptives — Semaglutide's effect on gastric emptying may affect absorption of oral medications. Consider taking birth control at a consistent time relative to meals, or discuss alternative contraception.
- ✓Warfarin — May affect warfarin absorption and metabolism. More frequent INR monitoring recommended when starting or changing semaglutide doses.
- ✓Levothyroxine — Take thyroid medication on an empty stomach as usual. Semaglutide shouldn't significantly affect absorption if taken at different times.
With supplements
- ✓Vitamin B12 — Long-term GLP-1 use may reduce B12 absorption. Consider B12 supplementation, especially if you've been on semaglutide for over a year.
- ✓Fiber Supplements — Can help manage constipation from semaglutide. Start slowly to avoid worsening GI symptoms. Psyllium husk is a good option.
- ✓Protein Supplements — Helpful for ensuring adequate protein intake when appetite is reduced. Aim for at least 60-80g protein daily to preserve muscle mass during weight loss.
- ✓Probiotics — May help with GI side effects. Some users find them helpful for digestive comfort during semaglutide therapy.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs weeks 1-4 (0.25mg dose)
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Imagine your gut has a 'fullness hormone' called GLP-1 that tells your brain when you've eaten enough. The problem is, this natural hormone only lasts a few minutes before breaking down. Semaglutide is like a super-powered, long-lasting version of that hormone. It's been modified so it stays active in your body for a whole week instead of minutes. When you take it, your brain gets a continuous 'I'm satisfied' signal, making you naturally want to eat less. It also slows down how fast food leaves your stomach, so you feel full longer after smaller meals. The result? You lose weight because you're genuinely less hungry—not because you're white-knuckling through deprivation.
Semaglutide is a GLP-1 receptor agonist with 94% homology to native human GLP-1, featuring key modifications: an amino acid substitution at position 8 (Ala→Aib) providing DPP-4 resistance, and acylation with an 18-carbon fatty diacid chain attached via a spacer at Lys26, enabling non-covalent albumin binding. This results in a half-life of approximately 168 hours (vs. 2-3 minutes for native GLP-1), allowing once-weekly dosing. Mechanistically, semaglutide activates GLP-1 receptors in multiple tissues: pancreatic beta cells (glucose-dependent insulin secretion), pancreatic alpha cells (glucagon suppression), gastric mucosa (delayed gastric emptying), and hypothalamic neurons (appetite suppression via POMC/CART activation and NPY/AgRP inhibition). The weight loss effects primarily derive from central nervous system actions reducing hunger, increasing satiety, and decreasing food reward signals. Cardiovascular benefits appear multifactorial, involving direct vascular effects, anti-inflammatory actions (reduced hsCRP), improved lipid profiles, and secondary effects from weight loss and glycemic improvement.
What to expect
Weeks 1-4 (0.25mg dose)
What you might notice
- •Mild nausea, especially after eating larger meals
- •Possibly feeling full slightly faster than usual
- •Minimal to no weight loss yet—this is the adjustment phase
- •Some people feel nothing at this dose, which is completely normal
What's normal
- •GI symptoms that come and go
- •Still feeling hungry between meals
- •Weight staying roughly the same
- •Getting used to the injection routine
What's next
- →After 4 weeks, increase to 0.5mg
- →Continue eating normally—don't force portion changes yet
- →Establish your weekly injection routine
Weeks 5-12 (0.5-1.0mg doses)
What you might notice
- •Noticeably reduced appetite and food thoughts
- •Feeling full on smaller portions
- •Weight loss beginning—typically 2-4 pounds in first month at effective doses
- •GI side effects may temporarily increase with each dose increase, then improve
What's normal
- •Nausea for a few days after dose increases
- •Smaller meals feeling satisfying
- •Early weight loss, though amounts vary widely between people
- •Reduced interest in snacking or large portions
What's next
- →Continue gradual dose increases every 4 weeks
- →Start focusing on protein-rich, nutrient-dense foods
- →Notice how your relationship with food is changing
Weeks 13-20 (1.7-2.4mg doses)
What you might notice
- •Significant appetite suppression—may need reminders to eat
- •Steady weight loss of 1-2 pounds per week
- •Food cravings much more manageable
- •GI symptoms typically stabilizing at this point
What's normal
- •Eating 30-50% less than before without feeling deprived
- •Less interest in formerly tempting foods
- •Clothes fitting looser, physical changes becoming visible
- •Improved energy as weight comes off
What's next
- →Reach and maintain the 2.4mg dose for ongoing weight management
- →Focus on building sustainable eating habits
- →Add or increase physical activity as comfortable
Months 6-12 and beyond
What you might notice
- •Approaching or reaching weight loss goals (average 15% of starting weight)
- •Metabolic improvements visible on lab work
- •New relationship with food and eating habits established
- •Side effects typically minimal or absent at this stage
What's normal
- •Weight loss slowing as you approach a new steady state
- •Maintaining reduced appetite at the 2.4mg dose
- •Lab improvements in blood sugar, cholesterol, inflammation markers
- •Needing to update wardrobe multiple times
What's next
- →Continue maintenance therapy—weight typically returns if medication is stopped
- →Work with your doctor on long-term plan
- →Focus on lifestyle habits that support maintaining your progress
Signs it's working · Appetite and Eating Behavior
- ✓Feeling satisfied with smaller portions
- ✓Fewer food cravings, especially for sweets and fatty foods
- ✓Reduced 'food noise'—less constant thinking about food
- ✓Natural tendency to choose healthier options
- ✓No longer feeling controlled by hunger
Signs it's working · Weight and Body Composition
- ✓Scale weight consistently trending downward
- ✓Clothes fitting looser, needing smaller sizes
- ✓Visible changes in face, waist, and other areas
- ✓Waist circumference decreasing
- ✓Progress photos showing clear differences
Signs it's working · Health Markers (via lab tests)
- ✓Blood sugar levels improving (especially HbA1c for diabetics)
- ✓Blood pressure decreasing toward normal
- ✓Cholesterol panel improving (lower LDL, triglycerides)
- ✓Reduced inflammatory markers (hsCRP)
- ✓Liver enzymes improving if previously elevated
Not seeing results? Common reasons
- •Not at therapeutic dose yet—most weight loss happens at 1.7-2.4mg doses; lower starting doses are for adjustment
- •Not waiting long enough—significant results typically take 3-6 months of consistent use at full doses
- •Eating through the medication—forcing yourself to eat large portions despite feeling full defeats the mechanism
- •Choosing calorie-dense foods—smaller portions of high-calorie foods can still prevent weight loss
- •Underlying metabolic conditions—thyroid disorders, PCOS, or medications like steroids may slow progress
- •Dehydration affecting the scale—make sure you're drinking enough water for accurate weight readings
Key research
07 · Questions
Frequently asked
How much weight will I actually lose on semaglutide?+
Clinical trials showed an average of about 15% of body weight over 68 weeks—that's roughly 35 pounds for someone starting at 230 pounds. But results vary widely: about 30% of people lose more than 20% of their weight, while some lose less. Diet quality, physical activity, and individual biology all play roles.
Why do I have to start at such a low dose?+
The gradual dose escalation isn't about being cautious—it's essential for tolerability. Starting at the full dose would cause severe nausea and vomiting in most people. The 4-week increases let your GI system adapt gradually, making side effects much more manageable. Patience during this phase pays off.
What happens if I stop taking semaglutide?+
Most people regain significant weight after stopping—studies show about two-thirds of lost weight returns within a year. This isn't a moral failing; it's biology. The medication is treating the underlying metabolic and neurological drivers of obesity, and those return when the medication stops. Most people need long-term treatment.
Is semaglutide safe long-term?+
Current data from clinical trials extending to 4+ years shows a consistent safety profile. The SELECT trial followed patients for an average of 40 months and showed cardiovascular benefits, not harms. That said, it's a relatively new medication (approved 2017 for diabetes, 2021 for obesity), and longer-term monitoring continues.
Will I lose muscle along with fat?+
Some muscle loss occurs with any significant weight loss, including with semaglutide—roughly 25-40% of weight lost may be lean mass. To minimize this: prioritize protein (aim for 1g per pound of goal body weight), include resistance training, and ensure adequate total nutrition. Don't skip meals just because you're not hungry.
Can I drink alcohol on semaglutide?+
Alcohol isn't contraindicated, but many users find their tolerance decreases significantly. Alcohol can also worsen nausea and GI side effects, lower blood sugar (especially in diabetics), and provides empty calories that can slow weight loss. Most people naturally drink less because it just doesn't appeal to them as much.
Why is there a thyroid cancer warning?+
In rodent studies, semaglutide and other GLP-1 drugs caused thyroid C-cell tumors. However, rodents have many more GLP-1 receptors in their thyroid than humans. After years of widespread human use (millions of prescriptions), no clear increase in thyroid cancer has been seen. Still, it's contraindicated if you have a personal or family history of medullary thyroid cancer.
What's the difference between Ozempic and Wegovy?+
They're both semaglutide, just different doses and indications. Ozempic (max 2mg/week) is FDA-approved for type 2 diabetes. Wegovy (max 2.4mg/week) is FDA-approved for chronic weight management. If you don't have diabetes and want it primarily for weight loss, Wegovy is the appropriate product, though both cause weight loss.
08 · Further reading
History & related research
Studied for